Received Jul 17, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARCEL | VARICELLA (VARIVAX) | MERCK & CO. INC. | UNK | Z004454 | — |
Caller stated no patient symptoms have been reported.; medical assistant who reported VARIVAX involved in temperature excursion has been administered; This spontaneous report was received from a medical assistant on 14-Jul-2025 and refers to a patient of unknown age and gender. The patient's medical history, concurrent conditions and concomitant therapies were not reported. On 10-Jul-2025, the patient was vaccinated with an improperly stored dose of Varicella Virus Vaccine Live (Oka-Merck) (VARIVAX), vial (lot #Z004454, expiration date: 13-Feb-2027), 1 dose, (route, anatomical location, and dose number were not reported) Prophylaxis. The vaccine was reconstituted with sterile diluent (MERCK STERILE DILUENT) (route, lot# expiration date, dose, dose number were unspecified) for Prophylaxis. The administered dose of the vaccine experienced a temperature excursion of 36.5 Fahrenheit for 2 hours, 21 minutes and 5. With no Previous excursion was not reported. There was no adverse effect reported. No product quality complaint was involved. This is one of several reports from the same source.
Sterile diluent